| Dr Ingrid Paola Loma-miller, MD | |
|
6161 Kempsville Cir, Suite 315, Norfolk, VA 23502-3932 | |
| (757) 461-5400 | |
| (757) 461-3305 |
| Full Name | Dr Ingrid Paola Loma-miller |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 6161 Kempsville Cir, Norfolk, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336393701 | NPI | - | NPPES |
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
A new Rutgers study strengthens the theory that caffeine guards against certain skin cancers at the molecular level by inhibiting a protein enzyme in the skin, known as ATR. Scientists believe that based on what they have learned studying mice, caffeine applied directly to the skin might help prevent damaging UV light from causing skin cancer.
GlaxoSmithKline believes that conclusions drawn from the most recent meta-analyses published by Drs. Nissen et. al. and Furberg et. al. in the Journal of the American Medical Association do not confirm a difference in the safety profile of Avandia (rosiglitazone) and Actos (pioglitazone).
Shire plc, the global specialty biopharmaceutical company, has partnered with the Entertainment Industries Council (EIC) , the Lab School of Washington and other organizations in support of National Attention Deficit Hyperactivity Disorder Awareness Week to host "Fact or Fiction ADHD in America, a Capitol Hill Forum."
A well-defined CAPA system is essential for any biopharmaceutical company to drive quality improvements across the organization. Hence, it is imperative for biopharmaceutical organizations to measure the effectiveness of their CAPA processes to identify potential areas of improvement in their quality function.
Researchers at Moffitt Cancer Center and colleagues have demonstrated that the inhibition of signal transducer and activator of transcription 3 (STAT3) in mouse models of mantle cell lymphoma (MCL), an aggressive and incurable subtype of B-cell non-Hodgkin lymphoma that becomes resistant to treatment, can harness the immune system to eradicate residual malignant cells responsible for disease relapse.
› Verified 6 days ago
| Entity Name | Pinnacle Health Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932143427 PECOS PAC ID: 7618960493 Enrollment ID: O20040407000180 |
News Archive
A new Rutgers study strengthens the theory that caffeine guards against certain skin cancers at the molecular level by inhibiting a protein enzyme in the skin, known as ATR. Scientists believe that based on what they have learned studying mice, caffeine applied directly to the skin might help prevent damaging UV light from causing skin cancer.
GlaxoSmithKline believes that conclusions drawn from the most recent meta-analyses published by Drs. Nissen et. al. and Furberg et. al. in the Journal of the American Medical Association do not confirm a difference in the safety profile of Avandia (rosiglitazone) and Actos (pioglitazone).
Shire plc, the global specialty biopharmaceutical company, has partnered with the Entertainment Industries Council (EIC) , the Lab School of Washington and other organizations in support of National Attention Deficit Hyperactivity Disorder Awareness Week to host "Fact or Fiction ADHD in America, a Capitol Hill Forum."
A well-defined CAPA system is essential for any biopharmaceutical company to drive quality improvements across the organization. Hence, it is imperative for biopharmaceutical organizations to measure the effectiveness of their CAPA processes to identify potential areas of improvement in their quality function.
Researchers at Moffitt Cancer Center and colleagues have demonstrated that the inhibition of signal transducer and activator of transcription 3 (STAT3) in mouse models of mantle cell lymphoma (MCL), an aggressive and incurable subtype of B-cell non-Hodgkin lymphoma that becomes resistant to treatment, can harness the immune system to eradicate residual malignant cells responsible for disease relapse.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ingrid Paola Loma-miller, MD 6161 Kempsville Cir, Suite 315, Norfolk, VA 23502-3932 Ph: (757) 461-5400 | Dr Ingrid Paola Loma-miller, MD 6161 Kempsville Cir, Suite 315, Norfolk, VA 23502-3932 Ph: (757) 461-5400 |
News Archive
A new Rutgers study strengthens the theory that caffeine guards against certain skin cancers at the molecular level by inhibiting a protein enzyme in the skin, known as ATR. Scientists believe that based on what they have learned studying mice, caffeine applied directly to the skin might help prevent damaging UV light from causing skin cancer.
GlaxoSmithKline believes that conclusions drawn from the most recent meta-analyses published by Drs. Nissen et. al. and Furberg et. al. in the Journal of the American Medical Association do not confirm a difference in the safety profile of Avandia (rosiglitazone) and Actos (pioglitazone).
Shire plc, the global specialty biopharmaceutical company, has partnered with the Entertainment Industries Council (EIC) , the Lab School of Washington and other organizations in support of National Attention Deficit Hyperactivity Disorder Awareness Week to host "Fact or Fiction ADHD in America, a Capitol Hill Forum."
A well-defined CAPA system is essential for any biopharmaceutical company to drive quality improvements across the organization. Hence, it is imperative for biopharmaceutical organizations to measure the effectiveness of their CAPA processes to identify potential areas of improvement in their quality function.
Researchers at Moffitt Cancer Center and colleagues have demonstrated that the inhibition of signal transducer and activator of transcription 3 (STAT3) in mouse models of mantle cell lymphoma (MCL), an aggressive and incurable subtype of B-cell non-Hodgkin lymphoma that becomes resistant to treatment, can harness the immune system to eradicate residual malignant cells responsible for disease relapse.
› Verified 6 days ago
Peter M Dozier, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-8866 Fax: 757-668-8870 | |
Dr. Crystal Miller Proud, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 850 Southampton Ave, Norfolk, VA 23510 Phone: 757-668-9920 Fax: 757-668-9930 | |
James Richard Wyant, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr Ste 8610, Norfolk, VA 23507 Phone: 757-252-9015 Fax: 757-510-9041 | |
Dr. Paul A Sayegh, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 825 Fairfax Ave, Suite 710, Norfolk, VA 23507 Phone: 757-446-5888 Fax: 757-446-5918 | |
Mary Margaret Gleason, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 401 Gresham Dr, Norfolk, VA 23507 Phone: 577-668-4673 | |
Dr. Jerry H Morewitz, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 825 Fairfax Ave, Suite 710, Norfolk, VA 23507 Phone: 757-446-5888 Fax: 757-446-5918 | |
Dr. C. Arthur Nalls Iii, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 6353 Center Drive, Ste 204, Norfolk, VA 23502 Phone: 757-461-3313 Fax: 757-461-8363 |